Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Hellmann

Showing results (161-170 of 196) with videos related to

Pageof 20
Sort By:
Transplantation Proceedings|January 3, 2006
Addition of cladribine to induction/consolidation regimen does not impair peripheral blood stem cell mobilization and bone marrow harvest for autotransplantation in acute myeloid leukemia patientsJ Holowiecki, S Grosicki, M Sadus-Wojciechowska, et al.
Annals of Hematology|April 28, 2005
A multicenter, open, noncomparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, granulocyte colony-stimulating factor and mitoxantrone as induction therapy in refractory acute myeloid leukemia: a report of the Polish Adult Leukemia GroupA Wrzesień-Kuś, T Robak, A Wierzbowska, et al.
European Journal of Cancer (Oxford, England : 1990)|January 30, 2004
Second malignancies and Richter's syndrome in patients with chronic lymphocytic leukaemia treated with cladribineT Robak, J Z Blonski, J Gora-Tybor, et al.
Journal of Neurology|July 22, 2015
Frequent misdiagnosis of adult polyglucosan body diseaseMark A Hellmann, Or Kakhlon, Ezekiel H Landau, et al.
Scientific Reports|December 9, 2022
Obesity is associated with myelin oligodendrocyte glycoprotein antibody-associated disease in acute optic neuritisHadas Stiebel-Kalish, Kerstin Rubarth, Karny Shouchane-Blum, et al.
Scientific Reports|February 22, 2023
Author Correction: Obesity is associated with myelin oligodendrocyte glycoprotein antibody-associated disease in acute optic neuritisHadas Stiebel-Kalish, Kerstin Rubarth, Karny Shouchane-Blum, et al.
Plos One|December 7, 2023
Effectiveness of oral prednisone tapering following intravenous methylprednisolone for acute optic neuritis in multiple sclerosisAdi Wilf-Yarkoni, Kristina Feldmann, Kerstin Rubarth, et al.
Bone Marrow Transplantation|April 20, 2004
Treatment for primary refractory Hodgkin's disease: a comparison of high-dose chemotherapy followed by ASCT with conventional therapyJ Czyz, R Szydlo, W Knopinska-Posluszny, et al.
Medical Oncology (Northwood, London, England)|January 10, 2002
Rituximab (Mabthera, Rituxan) in patients with recurrent indolent lymphoma: evaluation of safety and efficacy in a multicenter studyJ Walewski, E Kraszewska, O Mioduszewska, et al.
Leukemia & Lymphoma|June 1, 1996
2-chlorodeoxyadenosine (2-CdA) in 2-hour versus 24-hour intravenous infusion in the treatment of patients with hairy cell leukemiaT Robak, M Błasińska-Morawiec, E Krykowski, et al.
Pageof 20

Showing results (161-170 of 196) with videos related to

Sort By:
Pageof 20
Transplantation Proceedings|January 3, 2006
Addition of cladribine to induction/consolidation regimen does not impair peripheral blood stem cell mobilization and bone marrow harvest for autotransplantation in acute myeloid leukemia patientsJ Holowiecki, S Grosicki, M Sadus-Wojciechowska, et al.
Annals of Hematology|April 28, 2005
A multicenter, open, noncomparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, granulocyte colony-stimulating factor and mitoxantrone as induction therapy in refractory acute myeloid leukemia: a report of the Polish Adult Leukemia GroupA Wrzesień-Kuś, T Robak, A Wierzbowska, et al.
European Journal of Cancer (Oxford, England : 1990)|January 30, 2004
Second malignancies and Richter's syndrome in patients with chronic lymphocytic leukaemia treated with cladribineT Robak, J Z Blonski, J Gora-Tybor, et al.
Journal of Neurology|July 22, 2015
Frequent misdiagnosis of adult polyglucosan body diseaseMark A Hellmann, Or Kakhlon, Ezekiel H Landau, et al.
Scientific Reports|December 9, 2022
Obesity is associated with myelin oligodendrocyte glycoprotein antibody-associated disease in acute optic neuritisHadas Stiebel-Kalish, Kerstin Rubarth, Karny Shouchane-Blum, et al.
Scientific Reports|February 22, 2023
Author Correction: Obesity is associated with myelin oligodendrocyte glycoprotein antibody-associated disease in acute optic neuritisHadas Stiebel-Kalish, Kerstin Rubarth, Karny Shouchane-Blum, et al.
Plos One|December 7, 2023
Effectiveness of oral prednisone tapering following intravenous methylprednisolone for acute optic neuritis in multiple sclerosisAdi Wilf-Yarkoni, Kristina Feldmann, Kerstin Rubarth, et al.
Bone Marrow Transplantation|April 20, 2004
Treatment for primary refractory Hodgkin's disease: a comparison of high-dose chemotherapy followed by ASCT with conventional therapyJ Czyz, R Szydlo, W Knopinska-Posluszny, et al.
Medical Oncology (Northwood, London, England)|January 10, 2002
Rituximab (Mabthera, Rituxan) in patients with recurrent indolent lymphoma: evaluation of safety and efficacy in a multicenter studyJ Walewski, E Kraszewska, O Mioduszewska, et al.
Leukemia & Lymphoma|June 1, 1996
2-chlorodeoxyadenosine (2-CdA) in 2-hour versus 24-hour intravenous infusion in the treatment of patients with hairy cell leukemiaT Robak, M Błasińska-Morawiec, E Krykowski, et al.
Pageof 20